Skip to main content

MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

30 Oct 2026 Evaluate
The sales surged to Rs. 2611.30 millions, up 37.27% for the September 2026 quarter as against Rs. 1902.25 millions during the corresponding quarter previous year.The Net Profit of the company reported a remarkable increase of 196.74% to Rs. 735.65  millions  from Rs. 247.91 millions in previous same quarter.OP of the company witnessed a marginal growth to 678.74 millions from 438.62 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 2611.30 1902.25 37.27 4827.15 3535.89 36.52 7298.08 6672.05 9.38
Other Income 74.36 135.92 -45.29 161.98 241.85 -33.02 437.19 362.16 20.72
PBIDT 678.74 438.62 54.74 1285.03 872.23 47.33 1787.53 1278.02 39.87
Interest 11.20 27.15 -58.75 15.09 78.27 -80.72 121.14 65.84 83.99
PBDT 1078.40 411.47 162.08 1680.80 793.96 111.70 1644.83 1212.18 35.69
Depreciation 94.71 76.92 23.13 185.01 153.77 20.32 310.20 270.47 14.69
PBT 983.69 334.55 194.03 1495.79 640.19 133.65 1334.63 941.71 41.72
TAX 248.04 86.64 186.29 373.95 181.74 105.76 365.90 252.03 45.18
Deferred Tax 113.72 -27.46 -514.13 146.72 -57.85 -353.62 -59.47 -47.89 24.18
PAT 735.65 247.91 196.74 1121.84 458.45 144.70 968.73 689.68 40.46
Equity 106.33 105.65 0.64 106.33 105.65 0.64 105.79 105.37 0.40
PBIDTM(%) 25.99 23.06 12.73 26.62 24.67 7.92 24.49 19.15 27.87
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..